(R)-1-(tert-butoxycarbonyl)-3-methylpyrrolidine-3-carboxylic acid

Catalog No.: 
ACYJLP405
CAS No.: 
2198242-27-0
Molecular Formula: 
C11H19NO4
Molecular Weight: 
229.13
(R)-1-(tert-butoxycarbonyl)-3-methylpyrrolidine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$76.00In stockInquiry
100mg97%$125.00In stockInquiry
250mg97%$188.00In stockInquiry
500mg97%$313.00In stockInquiry
1g97%$500.00In stockInquiry
5g97%$1897.00In stockInquiry
10g97%$3347.00In stockInquiry
25g97%$7809.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-1-(tert-butoxycarbonyl)-3-methylpyrrolidine-3-carboxylic acid
IUPAC Name(R)-1-(tert-butoxycarbonyl)-3-methylpyrrolidine-3-carboxylic acid
MDL No.MFCD34187130
Molecular FormulaC11H19NO4
Molecular Weight229.13
SMILESCC(C)(C)OC(N1C[C@@](C)(CC1)C(O)=O)=O
InChI KeyDTLBJDMWGRKALK-LLVKDONJSA-N
SynonymSCHEMBL17469418 | AT27830 | (3R)-1-(TERT-BUTOXYCARBONYL)-3-METHYLPYRROLIDINE-3-CARBOXYLIC ACID | 2198242-27-0
CAS No.2198242-27-0
PubChem CID86326747

Synthetic Route by SureRoute

1. ACYJLP405 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMZRI694 route compound structure diagram
    ACMZRI6941410783-77-5In Stock
  4. Then
  5. ACYJLP405 route product structure diagram
    ACYJLP4052198242-27-0In Stock
Inquiry

2. ACYJLP405 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYJLP405 route product structure diagram
    ACYJLP4052198242-27-0In Stock
Inquiry

3. ACYJLP405 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYJLP405 route product structure diagram
    ACYJLP4052198242-27-0In Stock
Inquiry

Comments (0)